Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
作者信息
Cornelison A M, Saliba R M, Afrough A, Dinh Y, Nieto Y, Bashir Q, Shah N, Parmar S, Hosing C, Popat U, Shpall E, Champlin R, Qazilbash M H
机构信息
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
Bone Marrow Transplant. 2016 Feb;51(2):307-9. doi: 10.1038/bmt.2015.242. Epub 2015 Oct 19.
Abstract
摘要
相似文献
1
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
Bone Marrow Transplant. 2016 Feb;51(2):307-9. doi: 10.1038/bmt.2015.242. Epub 2015 Oct 19.
2
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2015 Aug;21(8):1413-7. doi: 10.1016/j.bbmt.2015.03.025. Epub 2015 Apr 2.
3
4
Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Nephrol Dial Transplant. 2008 Mar;23(3):941-51. doi: 10.1093/ndt/gfm684. Epub 2007 Oct 19.
5
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
Eur J Haematol. 2016 Oct;97(4):342-7. doi: 10.1111/ejh.12736. Epub 2016 Feb 15.
6
Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Arch Pathol Lab Med. 2013 Sep;137(9):1304-8. doi: 10.5858/arpa.2012-0159-CR.
7
High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases.
Int J Hematol. 2016 Mar;103(3):299-305. doi: 10.1007/s12185-015-1922-x. Epub 2015 Dec 24.
8
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Blood Adv. 2018 Apr 10;2(7):769-776. doi: 10.1182/bloodadvances.2018016782.
9
[Prognostic factors in light chain amyloidosis].
Orv Hetil. 2015 Sep 27;156(39):1577-84. doi: 10.1556/650.2015.30241.
10
Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
Ann Hematol. 2009 Jul;88(7):681-5. doi: 10.1007/s00277-008-0652-z. Epub 2008 Dec 6.
引用本文的文献
1
Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.
Bone Marrow Transplant. 2016 Oct;51(10):1318-1322. doi: 10.1038/bmt.2016.132. Epub 2016 May 16.
2
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2015 Aug;21(8):1413-7. doi: 10.1016/j.bbmt.2015.03.025. Epub 2015 Apr 2.
本文引用的文献
1
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.
Blood. 2014 Oct 9;124(15):2325-32. doi: 10.1182/blood-2014-04-570010. Epub 2014 Aug 12.
2
3
A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?
Haematologica. 2013 Jun;98(6):988-92. doi: 10.3324/haematol.2012.079210.
4
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
J Clin Oncol. 2012 Dec 20;30(36):4541-9. doi: 10.1200/JCO.2011.37.7614. Epub 2012 Oct 22.
5
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.
Blood. 2011 Oct 20;118(16):4346-52. doi: 10.1182/blood-2011-01-330738. Epub 2011 Aug 9.
6
Outcome in renal Al amyloidosis after chemotherapy.
J Clin Oncol. 2011 Feb 20;29(6):674-81. doi: 10.1200/JCO.2010.30.5235. Epub 2011 Jan 10.
7
International uniform response criteria for multiple myeloma.
Leukemia. 2006 Sep;20(9):1467-73. doi: 10.1038/sj.leu.2404284. Epub 2006 Jul 20.
8
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood. 2006 Apr 15;107(8):3378-83. doi: 10.1182/blood-2005-07-2922. Epub 2006 Jan 5.
9
Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.
Kidney Int. 2005 Oct;68(4):1464-71. doi: 10.1111/j.1523-1755.2005.00559.x.
10
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
Am J Hematol. 2005 Aug;79(4):319-28. doi: 10.1002/ajh.20381.
Zotero 插件